Abstract
Tinospora cordifolia (Willd.) Miers ex Hook. f. & Thomson, a known immunomodulatory agent extensively used in ayurveda, has not been effectively validated for the mechanisms involved in immunomodulation and the identification of the active principles. The bioactive fraction of T. cordifolia (TBF) in methanol was used for nitric oxide (NO) radical scavenging activity, lipoxygenase (LOX) and cyclooxygenase (COX) dual inhibition and cytotoxicity studies. Production of the proinflammatory cytokines, tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in dendritic cell (DC) suspensions treated with lipopolysaccharide (LPS) was also studied. The bioactive principles involved were identified with ultra-performance liquid chromatography-quadrupole-time of flight mass spectrometric (UPLC-Q-ToF MS/MS) system. The results indicate significantly higher potency of TBF as compared to positive standards for LOX/COX inhibition with moderate NO radical scavenging activity and the fraction was also found to be non-cytotoxic to monocyte cells. A significant inhibition was also observed in TNF-α and IL-1β production in LPS-treated DC suspensions as compared to standards, rolipram and dexamethasone, respectively. 11 compounds were identified from TBF by MS/MS system. The potent inhibition of LOX and COX enzymes with moderate NO scavenging was indicative of a free radical scavenging-independent mechanism of immunomodulation. Further investigations into the active principles identified would result in the development of lead candidates with potent therapeutic implications.
Similar content being viewed by others
References
Broderick KE, Feala J, McCulloch A, Paternostro G, Sharma VS, Pilz RB, Boss GR (2006) The nitric oxide scavenger cobinamide profoundly improves survival in a Drosophila melanogaster model of bacterial sepsis. FASEB J 20:1865–1873. doi:10.1096/fj.06-5780com
Caminschi I, Lahoud MH, Shortman K (2009) Enhancing immune responses by targeting antigen to DC. Eur J Immunol 39:931–938. doi:10.1002/eji.200839035
Chang DM, Baptiste P, Schur PH (1990) The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes. J Rheumatol 17(9):1148–1157
Choi J-H, Do Y, Cheong C, Koh H, Boscardin SB, Oh Y-S, Bozzacco L, Trumpfheller C, Park CG, Steinman RM (2009) Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J Exp Med 206:497–505. doi:10.1084/jem.20082129
Copeland RA, Williams JM, Giannaras J, Nurnberg S, Covington M, Pinto D, Pick S, Trzaskos JM (1994) Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc Natl Acad Sci USA 91:11202–11206
De Caterina R, Zampolli A (2004) From asthma to atherosclerosis—5-lipoxygenase, leukotrienes, and inflammation. N Engl J Med 350:4–7. doi:10.1056/NEJMp038190
Dinarello CA (2000) Proinflammatory cytokines. Chest 118:503–508
Fiorucci S, Meli R, Bucci M, Cirino G (2001) Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? Biochem Pharmacol 62:1433–1438
Gheorghe KR, Korotkova M, Catrina AI, Backman L, Af Klint E, Claesson H-E, Rådmark O, Jakobsson P-J (2009) Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids. Arthritis Res Ther 11:R83. doi:10.1186/ar2717
Gordaliza M, García PA, del Corral JMM, Castro MA, Gómez-Zurita MA (2004) Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon 44:441–459. doi:10.1016/j.toxicon.2004.05.008
Hsi LC, Wilson LC, Eling TE (2002) Opposing effects of 15-Lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate: alteration in peroxisome proliferator-activated receptor. J Biol Chem 277:40549–40556. doi:10.1074/jbc.M203522200
Jacob J, Kumar PB (2013) Ayurvedic herb, Tinospora cordifolia: validation of anti-inflammatory and immunomodulatory activity by effect on inflammatory mediators, TNF-α and lipoxygenase isozymes. JPRBioMedRx Int J 1(9):861–864
Jacob J, Prakash KB, Abhimannue AP, Mohan M, Babu BM (2014) Inhibition of lipoxygenase enzymes by extracts of Tinospora cordifolia: a study of enzyme kinetics. J Nat Prod 7:203–209
Kern JA, Lamb RJ, Reed JC, Daniele RP, Nowell PC (1988) Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest 81(1):237–244
Korhonen R, Hömmö T, Keränen T, Laavola M, Hämäläinen M, Vuolteenaho K, Lehtimäki L, Kankaanranta H, Moilanen E (2013) Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1. Br J Pharmacol 169(7):1525–1536
Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA (1998) Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 160:4090–4097
Li Z, Geng Y-N, Jiang J-D, Kong W-J (2014) Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid Based Complement Alternat Med 2014:289264. doi:10.1155/2014/289264
Marjanović M, Kralj M, Supek F, Frkanec L, Piantanida I, Smuc T, Tusek-Bozić L (2007) Antitumor potential of crown ethers: structure-activity relationships, cell cycle disturbances, and cell death studies of a series of ionophores. J Med Chem 50:1007–1018. doi:10.1021/jm061162u
Palmer G, Guerne PA, Mezin F, Maret M, Guicheux J, Goldring MB, Gabay C (2002) Production of interleukin-1 receptor antagonist by human articular chondrocytes. Arthritis Res Therapy 4(3):226–231
Parente L (2001) Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one? J Rheumatol 28:2375–2382
Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA (1994) Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890–896. doi:10.1038/ki.1994.117
Pinto NB, Morais TC, Carvalho KMB, Silva CR, Andrade GM, Brito GAC, Veras ML, Pessoa ODL, Rao VS, Santos FA (2010) Topical anti-inflammatory potential of Physalin E from Physalis angulata on experimental dermatitis in mice. Phytomedicine 17(10):740–743. doi:10.1016/j.phymed.2010.01.006
Singh BP, Deepa (2015) Concept of immunomodulation in ayurveda and some immunomodulatory herbs. Int Ayurvedic Med J 3(7):2205–2212
Souness JE, Griffin M, Maslen C, Ebsworth K, Scott LC, Pollock K, Palfreyman MN, Karlsson JA (1996) Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNFα generation from human monocytes by interacting with a ‘low-affinity’ phosphodiesterase 4 conformer. Br J Pharmacol 118(3):649–658
Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271–296. doi:10.1146/annurev.iy.09.040191.001415
Tsai P-J, Tsai T-H, Yu C-H, Ho S-C (2007) Comparison of NO-scavenging and NO-suppressing activities of different herbal teas with those of green tea. Food Chem 103:181–187. doi:10.1016/j.foodchem.2006.08.013
Verma R, Juvekar AR, Gopalkrishnan R (2006) Bioassay guided purification of an immunomodulatory polysaccharide from roots of Tinospora cordifolia. Planta Medica 72(11):P_002. doi:10.1055/s-2006-949802
Wang P, Myers JG, Wu P, Cheewatrakoolpong B, Egan RW, Billah MM (1997) Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D. Biochem Biophys Res Commun 234:320–324
Yang K, Ma W, Liang H, Ouyang Q, Tang C, Lai L (2007) Dynamic simulations on the arachidonic acid metabolic network. PLoS Comput Biol 3:e55. doi:10.1371/journal.pcbi.0030055
Zhang J-M, An J (2007) Cytokines, inflammation, and pain. Int Anesthesiol Clin 45:27–37. doi:10.1097/AIA.0b013e318034194e
Acknowledgements
The authors would like to thank Dineep Devadasan, Inter University Instrumentation Center, Mahatma Gandhi University, Kottayam, Kerala for MS/MS instrumentation and the Department of Biotechnology BUILDER Programme (Grant Number: BT/PR4800/INF/22/152/2012) for other instrumentation facilities. The study was supported by Grants from the Department of Biotechnology, Ministry of Science and Technology, New Delhi (Grant Number: BT/PR14926/PBD/17/720/2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Jacob, J., Babu, B.M., Mohan, M.C. et al. Inhibition of proinflammatory pathways by bioactive fraction of Tinospora cordifolia . Inflammopharmacol 26, 531–538 (2018). https://doi.org/10.1007/s10787-017-0319-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-017-0319-2